Cytokines may play an important role in the regulation of host defense against local bacterial infections. We have evaluated the local production of cytokines in a BALB/c mouse model of Escherichia coli pyelonephritis. Kidneys, draining lymph nodes, and spleens, were harvested at specific time intervals after bladder inoculation with E. coli corresponding to the stages of renal infection, infiltration, and bacterial clearance seen in this model. The presence of messenger RNA for specific cytokines (interleukins 1 through 6, chemotactic factors, granulocyte and granulocyte macrophage-colony stimulating factor
Cytokines are believed to play a role in the host response to bacterial infections. Specifically, they have been shown to aid in recruitment and chemotaxis of neutrophils, proliferation and function of other effector cells, and bacterial clearance (1) (2) (3) . Numerous studies have described the presence ofcytokines and kinetics oftheir production in overwhelming bacterial systemic and central nervous system infections (4) (5) (6) . Several inflammatory monokines (e.g., ILl, IL-6, and tumor necrosis factor-alpha [TNFa] )' have been detected in blood or cerebrospinal fluid and appear to contribute to a series ofphysiological events frequently culminating in death ofthe host. In contrast, less information has been obtained concerning the role ofcytokines in localized bacterial infections that are usually not lifethreatening and are often spontaneously cleared (7) (8) (9) . In this effective host response cytokines may contribute to the local eradication of bacterial pathogens. IL-6 has been detected in the urine but not serum of mice and humans after bladder inoculation with Escherichia coli, inferring local production of this cytokine in response to mucosal challenge with gram-negative bacteria (7, 8) . The cellular components responsible for this mucosal production of IL-6 have not been identified.
In this report, we have investigated in detail the local production of multiple cytokines in a murine model of unobstructed, ascending Escherichia coli pyelonephritis. Complete details ofthis murine model ofpyelonephritis that closely parallels the human infection will be presented elsewhere (Rugo, H. S., and P. O'Hanley, manuscript in preparation). Briefly, intravesicular administration of hemolytic E. coli strains leads to bacterial invasion of the renal parenchyma by 12 h after inoculation. Bacterial growth in the kidneys peaks after 2 to' 3 days with gradual resolution through day 7. Bacteria are spontaneously cleared from the kidney after day 10 
Methods
Experimental pyelonephritis. E. coli J96 strain (04, K6), a human pyelonephritis isolate, is globoside-binding, hemolytic, colicin V-positive, motile, and resistant to the bactericidal action of normal serum (10). 8-10-wk-old female BALB/c mice (Simonsen Laboratories, Gilroy, CA) were inoculated intravesicularly with 10' organisms of J96 strain in 100 ,l ofsaline as previously described (10) . Time intervals for RNA analysis were chosen to correlate with specific stages of infection, leukocyte infiltration, and bacterial clearance. Time points included the following: 12 h and 1, 2, 3, 5, 10, and 14 d after bacterial inoculation. All time points were evaluated at least twice in separate experiments. A total of 1O to 20 mice were killed at each time point. Kidneys, draining paraaortic lymph nodes and spleen were harvested in a sterile manner, flash frozen in liquid nitrogen, and stored at -80'C. Before freezing, kidneys were cut sagitally through the midpelvis and the cut surface was swabbed with a sterile swab. The swab was inoculated into trypticase soy broth and incubated with shaking at 370C overnight. The broth was then plated onto MacConkey agar plates, incubated for 24 h and observed for growth. The J96 strain was confirmed by slide agglutination with anti-O J96 sera (10) . Controls for urine studies included animals that received intravesical saline alone; controls for RNA analyses included batch matched animals.
Assay for IL-6 and TNFa in urine and serum. Urine and serum were obtained at 2, 4, 6, 12, 16, 24, 48 h, and 5 d after bacterial inoculation. IL-6 levels in the urine and serum and TNFa levels in the urine were determined by immunoenzymatic assay (I 1) using rat anti-mouse monoclonal antibodies to IL-6 and TNFa (12). The detection limit for these assays is 100 pg/ml. Serum TNFa levels were measured using the Walter and Eliza Hall Institute (WEHI) 164.13 fibrosarcoma bioassay as previously described (13) . The limit of detection for TNFa in this system is 1 pg/ml. RNA analysis. Organs and lymph nodes were crushed while frozen in liquid nitrogen with a sterile mortar and pestle. The frozen powder was then suspended in guanidinium isothiocyanate, layered onto cesium chloride and RNA was harvested as described (14) . RNA concentrations were estimated by spectrophotometry at 260 nm. First strand cDNA was synthesized using Abelson Maloney Virus (AMV) reverse transcriptase (Boehringer Mannheim, Indianapolis, IN) and oligo(dT) (Pharmacia Fine Chemicals, Piscataway, NJ) according to the method of Krug et al. (15) . 1 1tg of total RNA was reverse-transcribed for each sample and the control cell line, and l/2o of this mixture was amplified via the polymerase chain reaction (PCR) as described (16 (18) .
The sequences of additional primers for TGF#, H400, P500, TY5, and Table   cytokine synthesis inhibitory factor (CSIF/IL-l0) are listed in Table I . H400, P500, and TY5 belong to the 'sis' family of small inducible peptides and were deduced from cDNA cloned from concanavalin A activated mouse helper T cells (19) . CSIF/IL-10 was isolated and its DNA cloned from activated TH2 type helper T cells (20) . This novel cytokine has been shown to inhibit the synthesis and secretion ofIFN'Y in TH I type T cells (21).
Immunohistochemical staining. The method for immunohistochemical staining has been previously described (22). A modified procedure was employed for identification of cytokines in tissue sections (23) . Kidney tissue from mice inoculated with J96 strain 12, 24, and 48 h previously was snap frozen in liquid nitrogen and embedded in Tissue Tek II (Miles Labs, Naperville, IL). 5 Mm sections were cut and placed onto gelatin coated slides, air-dried for 20 min, fixed in 4% para-formaldehyde in 0.1 M phosphate buffered saline (PBS) for 10 min at 40C, then washed in PBS. Nonspecific staining was blocked by incubation in 10% normal mouse serum in PBS for 30 min. Rat monoclonal antibody to mouse IL-6 (clone 40F1 1) (12) at 20 jg/ml in 3% ovalbumin (Sigma Chemical Co., St. Louis, MO) in PBS, was incubated on sections at 4VC overnight, then for 1 h at room temperature. Slides were washed in PBS and then incubated for 15 min with affinity purified mouse antiserum to rat immunoglobulin F(ab')2 fragment (Jackson ImmunoResearch, Avondale, PA) at a 1:50 concentration in 5% human AB blood group serum in PBS. After washing in PBS, the sections were incubated for 15 min with rat peroxidase-anti-peroxidase complexes (Jackson ImmunoResearch) at a 1:50 dilution, then washed in PBS. Slides were stained with diaminobenzidine substrate and counterstained as described (22). The control for cytokine staining included normal mouse kidney tissue stained with anti-IL-6 antibody. Specificity was established by completely blocking anti-IL-6 antibody staining by adding an excess ofIL-6 protein to the initial incubation. Slides were examined by light microscopy for peroxidase staining.
Identification of membrane molecules defining infiltrating leukocyte subpopulations was performed on acetone-fixed cryostat sections from kidneys 12 to 48 h after inoculation. Primary antibodies employed and their specificities were as follows: RB6/8C5 (granulocytes), B220/6B2 (B cells), Lyt-1/53.7.3 (CD5 on T cells and a subpopulation of B cells); L3T4/GKI.5 (CD4 T cells); Lyt 2/53.6.7 (CD8 T cells) (Becton Dickinson, Mountain View, CA), and Mac I /M 1/70 (complement receptor type 3 on macrophages and neutrophils) (24) . Antibodies (10 jg/ml) were incubated on sections for 30 fication of kidney cDNA revealed a reproducible time course of gene expression for IL-1, IL-6, G-CSF, GM-CSF, TNFa, H400, and CSIF/IL-l0 (Fig. 1, A and B) . Infected kidneys expressed mRNA for these cytokines at 12 h and 1, 2, and 3 d following bacterial challenge. There was no signal or minimal signal seen for these cytokines after 5 d, no signal was seen at 10 or 14 d. No signal was seen in normal controls. The only exception was a weak signal for TNFa in normal controls and in mice 10 to 14 d after inoculation. RNA for the cytokines IL-2, 3, 4, 5, P500, and TY5 was not detectable at any time point among infected mice or in normal controls. Constitutive production was seen for lymphotoxin and transforming growth factor ,B, and weak production ofIFNy was seen only midinfection. In contrast to the cytokine production detected within the kidney, no induction ofcytokine mRNA was seen in the draining lymph node preparations. Analysis of spleen samples from infected and normal mice revealed only weak constitutive production of IL-6, TNFa, TNF(B and IFNy (data not shown).
These data suggest that there is a localized cytokine response to bacterial infection of the kidney. The cytokine response is confined to the kidney and does not involve extrarenal lymphoid organs.
The presence of IL-6 and TNFa proteins in the serum and urine was assessed from 2 to 48 h after infection. Earlier time points (2 to 12 h) were included because ofrecent data showing the rapid production and disappearance of inflammatory cytokines after systemic or local bacterial challenge (4, 7, 25) . IL-6 levels in the urine appeared as early as 4 h after inoculation and peaked at approximately 6 to 12 h after inoculation with gradual resolution over 24 to 48 h. The levels from six infected mice and sham catheterized controls are shown in Fig. 2 . Serum IL-6 levels were occasionally elevated above background as early as 2 h after inoculation, but this response did not correlate with the levels of urine IL-6. There were extremely variable background levels of serum IL-6. IL-6 was not detectable in the urine of control animals. TNFa was not detected in the serum (< 1 pg/ml) or urine (< 100 pg/ml) of mice challenged with bacteria.
Immunohistochemical staining of IL-6. Kidney sections were stained for IL-6 at 12 h and 1 and 2 d after intravesicular bacterial inoculation (Fig. 3) . Intense glomerular staining for IL-6 was seen at all time points examined after bacterial challenge. The distribution of IL-6 staining was characteristic of mesangial cell localization (Fig. 3, B staining seen in the normal kidney. Glomerular staining for IL-6 in infected mice was completely blocked by the addition of IL-6 protein to the tissue sections, confirming the specificity of staining for IL-6 (data not shown). In addition, there did not appear to be significant IL-6 production by the cells composing the inflammatory infiltrate in the infected kidney (Fig. 3 D) .
Pathology of murine E. coli pyelonephritis. The cellular basis for local cytokine production from 12 to 48 h after inoculation was assessed by immunohistochemical staining for cell surface markers in the kidney. Staining at 12 h after E. coli bladder inoculation revealed moderate focal infiltrates of neutrophils and possibly macrophages within the renal medulla and pelvis (cells stained with RB6/8C5 and Mac 1). The extent and intensity ofthese infiltrates increased up to 48 h after bacterial inoculation (Fig. 4) . The 48-h infiltrate did not contain cells expressing CD4 (Fig. 4) , CD8, Ly-l, and B220.
Discussion
This study demonstrates that mRNA for TNFa, IL-l, IL-6, G-CSF and GM-CSF, H400, and CSIF/IL-IO, is expressed locally in the kidney in response to E. coli pyelonephritis. The time course of expression for these cytokines differs significantly from that of an overwhelming systemic or central nervous system bacterial infection (4, 25) . In addition, it appears that production of IL-6 that is released into the urine in response to this infection is independent of serum levels, and that this cytokine may be produced within the glomerulus. The site of production of additional cytokines seen in this model is under investigation. Previous investigators employing a murine model of E. coli pyelonephritis have described the presence of IL-6 in the urine as early as 2 h after inoculation but did not extend their study to the localization of cytokine production (7). IL-6 is found in the urine and not serum of both human volunteers and mice after intravesical challenge with gram-negative bacteria (7, 8) . High bacterial counts in the kidney and persistent infection in the murine study were found to correlate with higher urine IL-6 levels but not with serum IL-6 levels. In this study the peak concentration of IL-6 in the urine appeared to roughly correlate with the appearance of mRNA in the kidney for that cytokine. IL-6 levels in the serum did not correlate with levels in the urine in animals clearing the infection also suggesting a local source of production under independent control. RNA analysis extends these observations to include multiple cytokines that are produced in response to this local infection.
Inflammatory cytokines have also been evaluated in the serum, cerebrospinal fluid (CF), and pleural fluid after bacterial challenge. The serum levels of IL-1, IL-6, and TNFa have been shown to correlate with death in meningitis (5) and in infectious purpura (6) . In these studies, peak levels of TNFa, IL-l, and IL-6 occur within 3 h of bacterial challenge (4, 25) . Protein production has previously been shown to correlate with mRNA expression (26) . Recently, production of these cytokines in the CF has been shown to be independent of serum levels in response to challenge with lipopolysaccharide (4). Local production of TNF and IFN-y by pleural tissue in tuberculous pleuritis has been described and is thought to play an important role in the local tissue response to this chronic infection (9) . In addition, human synovial cells and fibroblasts have been shown to produce inflammatory cytokines which may be involved in the pathogenesis ofchronic arthropathies (27 (33, 34) . It is possible that low levels of IL-6 are sufficient to aid in bacterial clearance, or that the IL-6 effect is more important for late clearance (later than 24 h after inoculation) of bacteria from the kidney. Although pyelonephritis is an infection that usually involves the distal tubules and collecting ducts in the pelvis and medulla of the kidney, it is of interest that the glomerulus is the site ofproduction ofIL-6. Hence, the role ofIL-6 in this infection may be to regulate the local immune response at other sites within the kidney. Autocrine stimulation of mesangial cell proliferation may be triggered by an acute event such as pyelonephritis and lead to a chronic proliferative syndrome characterized by progressive renal insufficiency. Modulation of this abnormal proliferation may be possible by understanding the local host defense to acute injury.
The sequential release of TNFa, IL-1, and IL-6 has been demonstrated in the serum and CF of patients with meningococcal infections (4, 5) . In addition, a recent study has shown that antibodies to TNFa reduce IL-l and IL-6 appearance during lethal bacteremia suggesting that TNFa is an essential stimulus for the release of these inflammatory cytokines during septic shock (25) . However, Havell and Sehgal (35) investigated the role of TNF in stimulating IL-6 production in response to a Gram-positive bacterial infection with Listeria monocytogenes. Passive immunization of mice with anti-TNF antibodies before bacterial challenge resulted in complete blunting of the TNF response but no change in the markedly elevated levels of IL-6 in the serum and spleen, implying TNFindependent IL-6 production. In the current study, TNFa protein was not detected in the urine or serum as early as two h after infection although mRNA for this mediator was detectable by PCR. This suggests that the mechanism of mesangial IL-6 production in E. coli pyelonephritis may also be independent of systemic TNFa. H400, TY5, and P500 are members of a family of small inducible peptides (19) . H400 is identical to another recently described factor, macrophage inflammatory protein-l# (MIP-1,B) (36), and TY5 is identical to MIP-1a (37) . Injection of MIP-1 in vivo has been shown to enhance chemotaxis of neutrophils and monocytes and MIP-1 can also serve as a pyrogen in a prostaglandin-independent manner (38) . The time course of RNA production for H400 demonstrated in this model appears to further support the importance of MIP-1, particularly MIP-1B, in the in vivo induction of local inflammation. The known cell sources of MIP-1 a and 13 are T cells and macrophages. Further investigation of the pyelonephritis model is needed to determine the cell type responsible for MIP-1I (H400) production in the inflamed kidney.
In conclusion, this study has outlined a time sequence for cytokine RNA expression and IL-6 production following experimental E. coli pyelonephritis in a murine model. This time sequence differs from that described in a systemic or central nervous system infection. The renal cytokine RNA expression in this infection parallels the appearance of the inflammatory infiltrate and disappears as the inflammation and infection clears. Concentrations of IL-6 in the urine do not correlate with serum levels, as shown in prior studies. Immunohistochemical staining in this investigation provides the additional new information that IL-6 is produced within the glomerulus in this infection. This study provides confirmatory evidence that the kidney is a separate compartment with regard to cytokine production in response to local infection, and suggests that mesangial cells might play an important role in the pathogenesis of acute as well as chronic renal disease.
